Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00184210
Status:
TERMINATED
Last Update Posted:
2021-03-22
First Post:
2005-09-12
Brief Title:
Magnetic Resonance MR Spectroscopy of Breast Cancer Tissue
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
HR MAS MR Spectroscopy of Breast Cancer Tissue
Status:
TERMINATED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
the actual primary goal - establishment of an approved tissue biobank - was reached 1000 tissue samples were collected No motivation at this time for continuation as originally planned
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer The tissue specimen are analyzed by MR spectroscopy After MR the intact tissue specimen can be analyzed by other methods such as histopathology
The MR spectral profiles are compared to clinical findings such as the patients diagnosis lymph node status and tumor size
The MR spectral profiles are compared to clinical findings such as the patients diagnosis lymph node status and tumor size
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None